Breast Cancer News
The daily breast cancer news is a unique cancer news service that evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for breast cancer prevention, early detection and breast cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making breast cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Breast Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Please view the latest news regarding Breast Cancer below.
Recent Breast Cancer News
Biomarker Analysis Identifies Women Most Likely to Benefit From Kadcyla (May 20, 2013)
Among women with metastatic, HER2-positive breast cancer, those with the highest tumor HER2 levels benefit the most from the drug Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1), according... Continue Reading
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
A false-positive mammogram can cause long-term psychosocial harm, according to the results of a study published in the Annals of Family Medicine—in fact, three years later, women still suffer the psychological... Continue Reading
The use of combined hormone replacement therapy with estrogen plus progestin among postmenopausal women was associated with an increased risk of breast cancer, according to the results of a long-term analysis... Continue Reading
Women ages 50 to 74 who undergo mammography screening every other year have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms... Continue Reading
Breast cancer prognosis may be worse among black women than among white women regardless of the subtype of breast cancer. These results were presented at the 2013 annual meeting of the American Association... Continue Reading
The U.S. Food and Drug Administration (FDA) has approved Lymphoseek® (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients... Continue Reading
The Oncotype DX® Recurrence Score® result is a robust predictor of loco-regional recurrence in node-positive, estrogen receptor (ER)-positive patients treated with adjuvant hormonal therapy and chemotherapy,... Continue Reading
Exposure to ionizing radiation during radiation therapy for breast cancer may increase the risk of heart attack or heart disease later in life, according to the results of a study published in the New... Continue Reading
The U.S. Food and Drug Administration (FDA) has approved Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1) for the treatment of HER2-positive, metastatic breast cancer that has been previously... Continue Reading
